Replay available

Bristol-Myers Squibb Company (BMY) Q1 2025 Earnings Call

Bristol-Myers Squibb Company (NYSE: BMY) Q1 2025 earnings conference call, held 2025-04-24. Replay captured from the company's public earnings webcast.

Thu, April 24, 2025 at 8:00 AMendedReplay
Bristol-Myers Squibb Company (BMY) Q1 2025 Earnings Call

Hosted by

Featured presenters

Louisa Hector

Analyst, Berenberg

Mohit Bansal

Analyst, Wells Fargo

Adam Lankowski

Chief Commercialization Officer

Sean McCutcheon

Analyst, Raymond James

Evan Siegerman

Analyst, BMO Capital

Chris Berner

Board Chair and Chief Executive Officer

Jeff Meacham

Analyst, Citi

James Shin

Analyst, Deutsche Bank

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bristol-myers Squibb Company.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.037 Good day and welcome to the Bristol-Myers Squibb first quarter 2025 earnings conference 00:00:05.037 -- 00:00:06.498 call. 00:00:06.498 -- 00:00:08.941 All participants will be in a listen only mode. 00:00:08.941 -- 00:00:12.385 Should you need assistance, please signal conference specialists by pressing the star 00:00:12.385 -- 00:00:16.970 key followed by zero. After today's presentation, there will be an opportunity to ask 00:00:16.970 -- 00:00:22.276 questions. To ask a question, you may press star then one on your telephone keypad. 00:00:22.276 -- 00:00:25.820 And to withdraw your question, please press star then two. 00:00:25.820 -- 00:00:29.479 Please note this event is being recorded. I would now like to turn the conference over 00:00:29.479 -- 00:00:34.121 to Mr. Chuck Triano, Senior Vice President and Head of Investor Relations. 00:00:34.121 -- 00:00:36.744 Please go ahead, sir. 00:00:36.768 -- 00:00:40.795 Thank you, and good morning, everyone. We appreciate you joining our first quarter 2025 00:00:40.795 -- 00:00:45.924 earnings call. Joining me this morning with prepared remarks are Chris Berner, our board 00:00:45.924 -- 00:00:50.732 chair and chief executive officer, and David Elkins, our chief financial officer. 00:00:50.732 -- 00:00:55.701 Also participating in today's call are Adam Lankowski, our chief commercialization officer, 00:00:55.701 -- 00:01:00.157 and Sumit Hirawat, our chief medical officer and head of global drug development. 00:01:00.157 -- 00:01:04.604 Earlier this morning, we posted our quarterly slide presentation to BMS.com that you 00:01:04.604 -- 00:01:07.629 can use to follow along with Chris and David's remarks. 00:01:07.629 -- 00:01:11.595 Before we get started, I'll remind everybody that dur...